Strategic CFO Hire With a newly appointed Chief Financial Officer in May 2025, TriCore may be evaluating cost optimization, payer mix improvements, and procurement strategies. This creates an opening to offer financial and performance analytics, cost containment solutions, and vendor consolidation opportunities.

Direct-to-Consumer Launch The December 2024 launch of MyTriCore indicates interest in consumer-facing testing channels. This presents a sales opportunity for patient-facing test kits, telehealth integration, secure patient portals, and consumer marketing services to expand direct-to-consumer testing capabilities.

Logistics Partnership Renewed collaboration with MedSpeed in January 2025 shows reliance on specialized lab logistics. There is potential to offer enhanced sample transport optimization, real-time tracking, and integrated logistics analytics to improve turnaround times and service levels.

R&D Collaboration TriCore participates in research with University of New Mexico and biotech firms, signaling ongoing scientific collaboration. This could be leveraged to propose advanced assay development, genomic testing partnerships, and contract research services for academic and commercial biotech clients.

Broad Test Portfolio Offering over 2,900 tests across routine and specialized areas positions TriCore to be a strategic partner for hospital systems and clinics needing scalable lab capacity, high-complexity testing, and integrated reporting. Opportunities exist to bundle panels, credentialed reference testing, and data-driven insights for population health programs.